Oct 12, 2012, 07.10 PM | Source: CNBC-Awaaz
Oil & gas producer Reliance Industries, a flagship company of Mukesh Ambani group, is set to declare its quarterly earnings on Monday (may be after market hours).
Net sales are seen going up by 2.9 percent QoQ and 20.3 percent YoY to Rs 94,500 crore in the July-September quarter of 2012.
Gross refining margin is expected to be at USD 9-9.5 a barrel in the quarter gone by as against USD 7.6 a barrel in the previous quarter and USD 10.1 a barrel in a year ago period.
Investors should watch out for following factors:
Brent crude prices averaged at USD 110 a barrel, a rise of 1% over previous quarter. Brent crude hit a low of USD 89 a barrel in June and then rose to USD 116 a barrel in mid-August but settled near USD 111 a barrel. So some inventory gains are also expected.
SCRMs (Singapore Complex Refining Margins) averaged at USD 9.13 a barrel in the September quarter as against USD 6.65 a barrel in previous quarter.
The improvement in GRMs on quarter-on-quarter basis is led by improvement in diesel, kerosene, petrol and naphtha spreads. Petrochemicals spreads were almost stable QoQ.
The gas production from its KG-D6 basin is expected to average at around 28 mcmd as against 32 mcmd QoQ, say experts.
Higher other income due to high cash levels and weak rupee is going to support the bottomline of July-September quarter.
Buy Reliance Industries, Siemens: Sameet Chavan
Sameet Chavan of Angel Broking is of the view that
Buy Reliance Industries, Exide may hit Rs 132: Rajat Bose
Rajat Bose of rajatkbose.com recommends buying Rel
Optimistic on Reliance Industries: Mayuresh Joshi
Mayuresh Joshi of Angel Broking is optimistic on R
Reliance Industries may go above Rs 1100: Jai Bala
Jai Bala of Cashthechaos.com feels that Reliance I
Reliance Industries may hit Rs 1040, says Bhavin Desai
Bhavin Desai of Motilal Oswal Securities is of the
Downside risk to earnings still not over, overweight on IT: CLSA
Nandurkar feels downside risk to earnings is still
Ind-Swift: Outcome of board meeting
Ind-Swift at its meeting held on February 12, 2016
Healthcare sector to see 15% revenue growth in FY17: Ind-Ra
While expansion plans will continue to impact prof